Home › Osteosarcoma › Georgia
Osteosarcoma clinical trials in Georgia
10 studies for Osteosarcoma are looking for participants at sites in Georgia.
Cities in Georgia
Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
- Chilldren's Healthcare of Atlanta, Atlanta
RecruitingPhase 1
Up to age 50 · All sexes · Updated Sep 30, 2026 · NCT06492954Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
RecruitingPhase 2
Ages 12 to 39 · All sexes · Updated Sep 29, 2026 · NCT04616560Losartan + Sunitinib in Treatment of Osteosarcoma
- Children's Hospital of Atlanta, Atlanta
RecruitingPhase 1
Ages 10 and older · All sexes · Updated Sep 1, 2026 · NCT03900793Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
RecruitingPhase 3
Up to age 50 · All sexes · Updated Aug 25, 2026 · NCT05235165Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- Children's Healthcare of Atlanta, Atlanta
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Aug 3, 2026 · NCT06239272Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
- Arthur M. Blank Children's Healthcare of Atlanta, Atlanta
RecruitingPhase 1
Ages 1 to 30 · All sexes · Updated Jun 2, 2026 · NCT07144254Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated May 19, 2026 · NCT04901702Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Children's Healthcare of Atlanta - Egleston, Atlanta
RecruitingObservational study
All ages · All sexes · Updated May 18, 2026 · NCT01790152Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma
- Children's Healthcare of Atlanta, Atlanta
RecruitingPhase 1
12 Months · All sexes · Updated Dec 26, 2025 · NCT05400603From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.